ArticleRSC advances2026

Hybrid benzylidene thiazolidine-2,4-diones as potent apoptosis-inducing anticancer agents: design-driven optimization, cytotoxic profiling, and mechanistic validation in prostate cancer.

Saad Shaaban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.